Results 1 to 10 of about 79,526,962 (296)

Role of Interleukin 5 Inhibition in the Treatment of Eosinophilic Otitis Media. [PDF]

OTO Open, 2021
Breslin NK, Heindel NH, Haberman RS.
europepmc   +1 more source

Effect of Biologics against Interleukin-5 Administered to Patients with Eosinophilic Gastroenteritis. [PDF]

Intern Med
Miyaguchi K, Matsumoto H, Shiomi R, Yamaguchi H, Tsuzuki Y, Imaeda H.   +5 more
europepmc   +1 more source

Anti-interleukin-5 efficacy in an inclisiran-triggered eosinophilic myocarditis: a case report. [PDF]

Eur Heart J Case Rep
Tartaglia F, Messina MR, Rizzo S, Heffler E, Panico C.   +4 more
europepmc   +1 more source

Use of intraoperative frontal sinus mometasone-eluting stents decreased interleukin 5 and interleukin 13 in patients with chronic rhinosinusitis with nasal polyps. [PDF]

Int Forum Allergy Rhinol, 2022
Schneider AL, Racette SD, Kang AK, Reddy AT, Huang JH, Lehmann DS, Price CPE, Eide JG, Rodeghiero SR, Conley DB, Welch KC, Kern RC, Shintani-Smith S, Peters AT, Kato A, Stevens WS, Schleimer RP, Tan BK.   +17 more
europepmc   +1 more source

Remarkable increase in Interleukin-5 receptor expression beyond tissue eosinophils in inflammatory bowel disease. [PDF]

Front Immunol
Kim YI, Oh HJ, Yang HR.
europepmc   +1 more source

Clinical utility of anti-interleukin 5 monoclonal therapy in asthma using a national, centralised, outcome-based system of drug access. [PDF]

BMJ Open Respir Res, 2022
O'Leary C, Schultz C, Walsh C, Adams R, Casey D, Lane S, Harrison M, Doyle S, Costello RW, King F, Murphy DM.   +10 more
europepmc   +1 more source

Correspondence to 'Interleukin-5 as a Pleiotropic Cytokine Orchestrating Airway Type 2 Inflammation: Effects on and Beyond Eosinophils'. [PDF]

Allergy
McCrae C, Jison ML, Menzies-Gow A.
europepmc   +1 more source

Severe hypereosinophilic syndrome successfully treated with a monoclonal antibody against interleukin 5 receptor α - benralizumab. [PDF]

Cent Eur J Immunol, 2021
Kosałka-Węgiel J, Milewski M, Siwiec A, Strach M, Ochrem B, Korkosz M.   +5 more
europepmc   +1 more source

Anti-interleukin-5/anti-interleukin-5 receptor α treatment improves self-reported work productivity in patients with severe eosinophilic asthma: a prospective cohort trial. [PDF]

ERJ Open Res
Brinkmann L, Fuge J, Welte T, Suhling H, Drick N.   +4 more
europepmc   +1 more source

Development of Rheumatoid Arthritis During Anti-Interleukin-5 Therapy in a Patient with Refractory Chronic Eosinophilic Pneumonia. [PDF]

J Asthma Allergy, 2021
Kawabata H, Satoh M, Yatera K.
europepmc   +1 more source